Associate Research Professor
Community Health and Prevention
267.359.6283
ml3629@drexel.edu
Download CV

Degrees

MD, University of La Salle, Mexico
PhD, Epidemiology, Johns Hopkins University, School of Public Health
ScM, Epidemiology, Johns Hopkins University, School of Public Health

Bio

Dr. Mariana Lazo’s current research interest involves understanding the contributions of socioeconomic and neighborhood conditions to the distribution of chronic liver diseases and risk factors (alcohol consumption and obesity), and to the observed disparities by race/ethnicity (particularly among Hispanics), by SES, and across and within cities in Latin American countries.

Dr. Lazo’s work has employed a broad scope of methodologies from primary data collection, to secondary data analyses of US national surveys and cohort studies, systematic reviews, and the conduct of clinical trials.

Dr. Lazo has conducted work in the U.S. but also internationally in Latin America.

Research Interests

• Racial/Ethnic Health Disparities
• Hispanic/Latino Health
• Social Determinants of Health
• Community-Based Participatory Research
• Urban Health
• Epidemiology of Obesity and Diabetes
• Epidemiology of Cardiovascular Diseases
• Epidemiology of Alcohol Consumption
• Epidemiology of Chronic Liver Diseases

Publications

Tabibian JH, Lazo M, Durazo FA, Yeh H-C, Clark JM. Nonalcoholic fatty liver disease: Features & differences in an ethno-racially diverse university setting. J Clin Gastroenterol. 2011 Mar;26(3):501-9. PMID: 21332546.

Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, Wagenknecht LE, Pi-Sunyer FX, Kahn SE, Clark JM; for the Fatty Liver Subgroup of the Look AHEAD Research Group. The Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults with type 2 Diabetes. Diabetes Care. 2010 Oct;33(10):2156-63. PMID: 20664019.

Hill-Briggs F, Lazo M, Peyrot M, Chang Y, Doswell A, Bone L, Hill M, Levine D, Brancati FL. Effect of problem-solving-based Diabetes self-management training on diabetes control in a low income patient sample. J Gen Intern Med. 2011 Sep;26(9):972-8. PMID: 21445680.

Lazo M, Hernaez R, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Nonalcoholic Fatty Liver Disease and Mortality among US Adults: A prospective cohort study. BMJ. 2011 Nov 18;343:d6891. PMID: 22102439.

Lazo M*, Hernaez R*, Eberhardt M, Bonekamp S, Kamel I, Guallar E, Koitesh A, Brancati FL, Clark JM. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013 Jul 1;178(1):38-45. PMID: 23703888. [*Co-first authors]

Liu SH, Lazo M, Koitesh A, Kao WHL, Shih M, Bonekamp S, Hernaez R, Clark JM. Oral Contraceptive Pill Use Is Associated with Reduced Odds of Nonalcoholic Fatty Liver Disease in Menstruating Women: Results from NHANES III. Journal of Gastroenterology. 2013 Oct;48(10):1151-9. PMID: 23188092.

Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, Vaidya D. Association Between Endogenous Sex Hormones and Liver Fat in a Multi-Ethnic Study of Atherosclerosis. Clinical Gastroenterology and Hepatology. 2015. 2015 Sep;13(9):1686-93. PMID: 25592661.

Lazo M, Nwankwo C, Daya NR, Thomas DL, Mehta SH, Juraschek S, Willis K, Selvin E. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. Clin Gastroenterol Hepatol. 2017;15(12):1957-1964. PMID: 28579183.

Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hedge SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE. Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2018;137(20):2142-2151. PMID: 29386202.

He X, Rebholz CM, Daya N, Lazo M, Selvin E. Alcohol Consumption and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia. 2019; 62(5):770-778. PMID: 30820594.

Additional Publications via PubMed